Numares Health, based in Regensburg, Germany, is an innovative diagnostics company that applies machine learning to metabolomics and other biomarker data to develop advanced tests for clinical diagnostics. The FDA-cleared AXINON® System makes next-generation use of nuclear magnetic resonance (NMR) spectroscopy to evaluate metabolic constellations. Magnetic Group Signaling (MGS®) is a proprietary technology that enables NMR for highly standardized and rapid throughput testing. Metabolic tests are an important part of addressing unmet needs in cardiovascular, kidney and liver neurological diseases. Numares AG Am BioPark 9 93053 Regensburg Phone: +49 941 280 949-00 Fax: +49 941 280 949-50 E-Mail: info@numares.com www.numares.com Executive Board: Dr. Claus Botzler, Florian Voß Supervisory Board: Uwe Steinbacher (chairman), Volker Pfahlert, Kathy L. Bates, Dr. Rainer Kutzner, Dr. Gerhard Ries, Dr. Gregory F. Heath Registered office: Regensburg Location of court: Regensburg HRB 14269 VAT-ID: DE 236 532 262
